How do I buy Vor Biopharma Inc. Common Stock (VOR) stock?

Buying Vor Biopharma Inc. Common Stock (VOR) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and complete KYC. Make a deposit. Search for the code "VOR", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy VOR by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for VOR on Gotrade?

On Gotrade, you don't have to buy a full lot. With fractional shares, you can start investing in Vor Biopharma Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does Vor Biopharma Inc. Common Stock (VOR) pay dividends?

At the moment, Vor Biopharma Inc. Common Stock (VOR) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track VOR's performance via the price chart in the Gotrade app.

Is buying VOR on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy VOR?

You can place orders 24/7. Transactions will be executed when the US market (NYSE/NASDAQ) is open, from 9:30 PM to 4:00 AM WIB. Gotrade also provides access to pre-market and after-hours trading, so you have more flexibility and aren't limited to regular working hours. Market hours may change due to daylight saving time and holidays. In Gotrade, you can see the market status (open/closed) directly in the app.

How do I tell if VOR is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Vor Biopharma Inc. Common Stock (VOR) Stock Price: Oct 8 Close $19.13

Latest news

Zacks Investment Research

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

VORMay 7, 2026

Zacks Investment Research

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

VOR

Zacks Investment Research

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

VORApril 20, 2026

Zacks Investment Research

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

VOR

Zacks Investment Research

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

VORApril 2, 2026

Zacks Investment Research

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

VOR

Zacks Investment Research

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

VORApril 2, 2026

Zacks Investment Research

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

VOR

Stocktwits

VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage

VORDecember 9, 2025

Stocktwits

VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage

VOR

Stocktwits

Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch

VORDecember 9, 2025

Stocktwits

Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch

VOR

Zacks Investment Research

About Vor Biopharma Inc. Common Stock

No description available.

SectorHealthcare

IndustryBiotechnology

Employees76

CEODr. Jean-Paul Kress M.D.

IPO DateFeb 5, 2021

HeadquartersBoston, MA

Key Executives

Name	Title	Year Born
Dr. Jean-Paul Kress M.D.	Chairman, President & CEO	1965
Mr. Sandesh Mahatme L.L.M.	Chief Business Officer & CFO	1965
Dr. Robert Ang M.B.A., M.D., MBBS	Strategic Advisor	1975
Dr. Siddhartha Mukherjee DPHIL, M.D., Ph.D.	Scientific Founder & Chairman of Scientific Advisory Board	1971
Ms. Adi Osovsky	General Counsel	—
Ms. Carol Lincoln CCP	Head of Human Resources	—
Mr. Dallan Murray	Chief Commercial Officer	1970
Dr. Navid Z. Khan Ph.D.	Chief Medical Affairs Officer	—
Dr. Jeremy Sokolove M.D.	Chief Medical Officer	1974

Fundamentals

Valuation

Market cap$1.13B

Price-to-book value-5.55

Price-earnings ratio1.80

Return on Equity-92.00%

Return on Assets154.00%

Earnings Per Share

Earnings Per Share$179.71

Income Statement

Average volume1,282,614

EBITDA$628.25M

1 year high (52w)$34.63

1 year low (52w)$6.50

Dividend

Dividend amount$0.00

Dividend yield0.00%

Source: third-party data provider, as of October 9, 2026

Technical indicators

RSI 14: 42.37
MACD 12/26/9: -1.01
EMA 9 of MACD: -0.96
MACD histogram: -0.05
SMA 50: $21.90; Price below SMA 50
EMA 50: $20.50; Price below EMA 50
SMA 200: $16.86; Price above SMA 200
EMA 200: $18.07; Price above EMA 200

Calculated by Gotrade from daily closing prices, as of October 8, 2026. Technical data, not a recommendation.

Analyst views

1 analyst rating

Third-party analyst opinion, not a recommendation from Gotrade.

Analyst consensus:Hold

0% Buy

100% Hold

0% Sell

Analyst price target

Low: $27.00
Average: $27.00
High: $27.00

Wedbush

Martin Fan

Hold

Target price

$27.00

Seasonality

Monthly price change (%)

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021										+11.6	-29.7	+2.7
2022	-32.5	+4.6	-31.7	-9.3	-28.6	+23.0	-4.2	+5.3	-25.0	+22.4	-1.9	+40.0
2023	-22.0	+5.5	-2.4	-14.9	+9.6	-34.8	+2.0	-21.1	-20.6	-6.4	+11.8	+17.2
2024	+3.1	-2.1	+4.4	-21.8	-23.7	-30.1	-6.1	-7.0	-16.0	+31.7	+3.4	+27.7
2025	+26.8	-19.4	-24.6	+9.5	-69.7	+590.8	+44.8	-6.2	+19.4	-38.6	-62.8	+70.3
2026	+11.7	+20.7	+12.2	-17.6	+8.1	+26.4	+15.0	+5.0	-15.7	+5.9

Compare stocks

VOR

Buy VOR

Market cap

$1.13B

-

Price / Earnings ratio

1.80

-

Price / Sales ratio

-

Dividend yield

0.00%

-

Average volume

1,282,614

-

Earnings per share

$179.71

-

Vor Biopharma Inc. Common Stock (VOR) Stock

Fundamentals

Compare with VOR

Recent news

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

Vor Biopharma (VOR) Upgraded to Buy: Here's Why

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

Wall Street Analysts Predict a 107.82% Upside in Vor Biopharma (VOR): Here's What You Should Know

VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage

VOR Shares Rally Over 40% In Pre-Market Trade After JPMorgan Initiates Bullish Coverage

Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch

Futures Tread Cautiously Pre-Market As Investors Await Key Fed Decision: NVDA, XCUR, GME, CASY Among Stocks To Watch

Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know

Vor Biopharma (VOR) Upgraded to Buy: Here's What You Should Know

The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness

The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness

About Vor Biopharma Inc. Common Stock

Key Executives

Fundamentals

Valuation

Earnings Per Share

Income Statement

Dividend

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trading Lebih Cepat. Lebih Mudah. Lebih Cerdas.

#ReadyGoTrade